Xolair works by binding to free immunoglobulin E (IgE) in the blood to prevent mast cell degranulation and the release of pharmacologically active substances that are the hallmark of the early allergic inflammatory process. (Source: ABPI)
-
The efficacy of Xolair has been investigated in a series of clinical trials... -
Xolair works by binding to free immunoglobulin E (IgE) in the blood to... -
It is believed that Xolair will be first marketed as maintenance therapy for...
